Human albumin (Baxalta)

人白蛋白（Baxalta）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman albumin (Baxalta)
Drug Alias NameFLEXBUMIN
ClassificationBiologics > Blood components
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsHypovolemiaHypoalbuminemia
Global Approved IndicationsHypovolemiaHypoalbuminemia
Approved Indications in ChinaHypovolemia
Original Approved Country/TerritoryUnited States
Original Approved Date2002/01/01
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBaxalta Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesBaxalta Incorporated
Inactive CompaniesN/A
Active IndicationsHypovolemiaHypoalbuminemia
Inactive IndicationsN/A

Other Information

ATC CodeB05AA01
Related LinksN/A